Hepatitis B and C

Section I: 1. Hepatitis B 2. Natural History of Hepatitis B: Epidemiology 3. Natural History of Hepatitis B: Hepatic Manifestations 4. Natural History of Hepatitis B: Extra-hepatic Manifestations and Quality of Life 5. Goal of Treatment in Chronic Hepatitis B 6. Efficacy of Interferon 7. Efficacy of Lamivudine 8. Comparison Between Lamivudine, Interferon, and Combination Interferon Lamivudine 9. Safety of Lamivudine 10. New Drugs Effective on YMDD Mutant 11. First Line Treatment of Chronic Hepatitis B: Lamivudine or Interferon? 12. Who Need to be Treated and how to Explain the Goals to the Patient 13. Management of Relapsers and Non-responders 14. Management of Patients Coinfected by HBV and HIV 15. Management of Transplanted Patients Infected by HBV 16. Cost-effectiveness of Treatment 17. Who Needs to be Treated 18. References
Section II: 19. Hepatitis C 20. Natural History of Hepatitis C: Epidemiology 21. Natural History of Hepatitis C: Hepatic Manifestations 22. Natural History of Hepatitis C: Extra-hepatic Manifestations and Quality of Life 23. Efficacy of Ribavirin and Standard Interferon Combination Regimen 24. Factors Associated with Response and 'a la Carte' Regimen 25. Efficacy of Pegylated Interferon 26. Efficacy of Combination with Pegylated Alpha-2 Interferon and Ribavirin 27. Management of Relapsers and Non-responders 28. Management of Patients with Cirrhosis 29. Management of Patients Coinfected by HCV and HIV 30. Management of HCV Infection Post Liver Transplantation 31. Safety of Standard Interferon and Ribavirin 32. Safety of Pegylated Interferon and Ribavirin 33. Who Needs to be Treated? 34. Cost-effectiveness of Treatment 35. Practical Guidelines for the Management of Hepatitis C 36. References